Current State of COPD with Dr. Gerard Criner
The Temple-based investigator and expert joins Lungcast to review recent clinical trials, recommendations and non-surgical techniques for patients who have advanced COPD.
The Temple-based investigator and expert joins Lungcast to review recent clinical trials, recommendations and non-surgical techniques for patients who have advanced COPD.
Geneoscopy’s ColoSense received FDA approval on May 06, 2024 based on data from the phase 3 CRC-PREVENT trial.
Vitamin D concentration was significant in chronic hepatitis B virus but not hepatitis C virus infection, suggesting its potential impact on immune response.
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…
Results showed the prevalence and treatment patterns for IgAN in select Asian Pacific countries and regions were not commonly available.
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
Lykos Therapeutics’ new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such…
In an interview, Ryan McLaughlin discussed the ethical concerns regarding treating psychiatric illness with cannabis.
Both overall TEAEs and serious TEAEs were numerically higher in those receiving upadacitinib compared with adalimumab.
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…